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Abstract 
Background: There is a large disparity between the number of people waiting for organ 
transplants and the number of organs available. Optimal hemodynamic management can 
influence transplant outcomes, therefore evidence-based hemodynamic management should be 
practiced to maximize scarce donor organs. 
Purpose: The purpose of this study was to examine intraoperative blood pressures and 
administration of volatile anesthetics during brain dead organ donor procurements.  Use of 
volatile anesthetics was examined to determine how use and dose affected the ability to maintain 
mean arterial pressure (MAP) between 60 to 90 mmHg. 
Design: This study was a retrospective chart review. 
Results: Twenty-eight cases were analyzed using the mean MAP calculated for each donor. 
Mean scores ranged from 61.04 to 99.34 mmHg with a mean of M= 84.51 mmHg. Twenty-two 
donors (78.6%) received volatile anesthetic gas, and six donors (21.4%) received no volatile 
anesthetic gas. Mean end-tidal concentrations of volatile anesthetic gas in the 22 donors who 
received volatile anesthetic gas ranged from 0 to 1.25% with a mean end-tidal concentration of 
M= 0.39%. Mean MAP in donors that did not receive volatile anesthetic gas was M= 78.49 
mmHg (SD= 9.78 mmHg). Mean MAP in donors that received volatile anesthetic gas was M= 
86.16 mmHg (SD= 7.02 mmHg). An independent samples t test performed between these two 
groups demonstrated that the difference between mean MAPs of the two groups was statistically 
significant (t= 2.182, p= 0.038), but no statistically significant correlation was found between 
mean MAP and mean end-tidal volatile anesthetic gas (rs= -0.184, p=0.414). 
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Conclusions: This study demonstrated that intraoperative hypertension is more prevalent than 
intraoperative hypotension, and volatile anesthetic gas is often used at this medical center during 
organ procurements at relatively low concentrations. 
  
INTRAOPERATIVE BLOOD PRESSURE  5 
Acknowledgements 
I would like to thank Dr. Pamela Schwartz, Jeff Matson, and Michael Harmon for their 
invaluable feedback as DNP committee members, and Dr. Jessica Bishop-Royse for lending her 
expertise is statistical analysis for this project. I would also like to thank Dr. Joseph Tariman and 
Dr. Young-Me Lee for their support and direction throughout the DNP project process. 
This work was supported in part by Health Resources and Services Administration 
contract 234-2005-37011C. The content is the responsibility of the authors alone and does not 
necessarily reflect the views or policies of the Department of Health and Human Services, nor 
does mention of trade names, commercial products, or organizations imply endorsement by the 
U.S. Government. 
 
  
INTRAOPERATIVE BLOOD PRESSURE  6 
Introduction 
Background and Significance 
Over 120,000 people are currently on the waiting list for organ transplants in the U.S.  
according to data from the United Network for Organ Sharing (UNOS) as of April 17, 2016 
(UNOS, n.d.). The vast majority of organ transplants come from deceased donors, and the 
incidence of organ transplantation in the U.S. has increased substantially since its official 
beginnings in 1988. However, during the past decade, deceased donor transplants have increased 
approximately six percent, down from the decade before when donations had increased 31 
percent according to data from the Organ Procurement and Transplantation Network (OPTN) as 
of April 8, 2016. While the growth of transplantation has slowed, the number of patients waiting 
for transplants has continued to climb, increasing 25.8% from 2005 to 2015 (OPTN, n.d). This 
gap has created a shortage of suitable, available organs for transplantation. This shortage has led 
to over 6,000 patients dying every year during the past decade while waiting for an organ 
transplant (OPTN, 2016). 
Several options have been proposed and trialed to increase the number of organs 
available for transplant including extended criteria donors, splitting organs, increasing living 
donors and donation after circulatory death, increasing donor registration, and organ perfusion 
devices utilized after procurement prior to implantation (Saidi & Hejazii Kenari, 2014). 
Optimizing the utilization of donor organs through better donor management preoperatively and 
intraoperatively allows more organs to be transplanted per donor, thereby increasing the number 
of patients being transplanted without an increase in the number of donors. Previous studies have 
reported that blood pressure (BP) control and treatment is crucial to organ perfusion and can 
greatly impact the quality and success of the transplant (Mukadam et al., 2005, Powner, 2005). 
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Sandid, Assi, and Hall (2006) found intraoperative hypotension during cadaveric organ donor 
procurement was an independent risk factor for slow kidney graft function in recipients (defined 
as a decline in serum creatinine by less than 50 percent by day three). 
Anderson, Bekker, and Vagefi (2015) assert that ―[t]he success of the anesthesiologist in 
physiological optimization of the brain-dead donor may eventually determine the outcome of the 
organ recipient‖ (p. 537). Additional research and dissemination of evidence on intraoperative 
BP control in brain dead organ donors could increase the success of transplantation by 
minimizing recipient graft function complications related to hypotension. ―Both initial and late 
circulatory changes can lead to severe ischemic damage in donor organs before their removal, 
causing deterioration of the quality of the transplanted graft‖ (Pratschke et al., 1999, p. 344). 
According to McKeown, Bonser, and Kellum (2012), hypotension occurs in 
approximately 81-97% of brain dead donors according to studies they reviewed. Conversely, 
elevations in BP can also occur intraoperatively as demonstrated by the study by Wetzel, Setzer, 
Stiff, and Rogers (1985). Ideal pharmacological treatment for BP derangements in brain dead 
donors differ from intraoperative care of living patients due to the pathophysiological changes of 
brain death and its sequelae. 
Significant variations in practice exist among anesthesia providers in regards to 
management of BP intraoperatively for brain dead organ donors. Many organ procurement 
organizations (OPOs) provide donor anesthesia guidelines to anesthesia providers for the 
procurement. Protocols for OPOs vary regionally, and many of these guidelines for BP 
management lack evidence based in current research. For example, the 2015 consensus statement 
on organ donor management by the Society of Critical Care Medicine, American College of 
Chest Physicians, and the Association of Organ Procurement Organizations (Kotloff et al., 2015) 
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B.C. Transplant, all still recommend dopamine as a first line agent for hypotension after the 
donor has been fluid resuscitated.  Kotloff et al. (2015) acknowledge dopamine as a first-line 
agent, but that it only continues to remain a first-line agent due to a lack of evidence to change 
the practice. Anesthesia providers’ adherence to guidelines is difficult to assess, and 
intraoperative donor management is often subject to an anesthesia provider’s anecdotal 
experience, as well as comfort with, and understanding of brain death. 
Problem Statement 
The cascade of brain death induces many physiological changes, which are well-
established in the literature. As a result, brain dead organ donors cannot be managed the same as 
living patients. Regulation of BP affects end-organ perfusion which is of key importance in 
viability of an organ transplant. Although gaps remain in the literature that prevent development 
of a comprehensive set of evidence based guidelines for BP management of brain dead organ 
donors, anesthesia providers should be equipped with the current evidence and guidelines 
available to manage BP in the setting of this unique physiology. 
Anesthesia providers infrequently encounter organ procurements surgeries, resulting in 
very little experience managing these unique physiological abnormalities. These procedures are 
often urgently added during off-peak hours, leading to additional stress and little time for 
preparation for an unfamiliar case. It is common for OPOs to provide the anesthesia team with a 
sheet of guidelines for intraoperative donor management for the procurement surgery. However, 
advisement and consensus of BP management during these surgeries is inconsistent and 
controversial when comparing the available evidence and the published guidelines. 
Purpose 
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The purpose of this study was to examine intraoperative BPs and administration of 
volatile anesthetics during brain dead organ donor procurement surgeries at a large medical 
center in the U.S. that encounters a large number of organ procurements. Hypotension was 
defined as a mean arterial pressure (MAP) less than 60 mmHg intraoperatively, and hypertension 
was defined as a mean arterial pressure (MAP) greater than 90 mmHg intraoperatively.  Use of 
volatile anesthetics was examined to determine how use and dose affected the ability to maintain 
MAP between 60 to 90 mmHg. 
Hemodynamic stability is crucial to organ perfusion in order to prevent ischemia. Van der 
Hoeven et al. (2000) suggest that maintaining normotension can limit the dysfunction of livers 
from brain dead donors, and therefore greatly impacts the quality and success of the transplant. 
Increasing availability and communication of necessary information to maintain hemodynamic 
stability in brain dead donors, based on current research, will increase successful transplantation 
by minimizing recipient graft function complications related to lack of donor BP control.  
Clinical Questions 
 This study addresses the following research questions: 
 Given the negative impact of hypotension (defined as MAP less than 60 mmHg) on 
transplanted organs, what has been the mean MAP and duration of intraoperative 
hypotension during organ procurements at a hospital with a high volume of organ donors? 
 Is there a dose-dependent relationship between the intraoperative administration of volatile 
anesthetics to brain dead organ donors and decreases in MAP? 
Literature Review 
Overview of the Literature Review Process 
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 A literature review was performed using PubMed, CINAHL, and WorldCat search 
engines using the following terms: brain dead organ donor, brain dea*, organ donation, 
intraoperative, management, anesthe*, hemodynamic, blood pressure, organ procurement, 
organ harvest, and surgery. Recent relevant peer-reviewed literature, as well as pertinent historic 
studies, related to managing both high and low BP, and the pathophysiology, proposed 
mechanisms, and treatments during organ procurement surgery were reviewed. For the purposes 
and scope of this literature review, interventions typically done in the intensive care unit (ICU) 
setting, such as initial fluid resuscitation and hormone replacement such as corticosteroids and 
thyroid hormones, were not included in the review. Adequate resuscitation and management 
prior to the operating room (OR) are key for optimizing hemodynamic stability. Even with such 
interventions to optimize hemodynamics prior to surgery, the BP variations intraoperatively 
often pose the most frequent and significant challenges for the anesthesia provider and have the 
potential to greatly impact the successful transplantation of organs in recipients. 
Conceptual Framework 
This study is guided by the Neuman’s system model (see Appendix B) for nursing 
created by Dr. Betty Neuman. The Neuman’s system model’s core philosophy is rooted in basic 
survival factors (Neuman, 2002). The response pattern to stressors is a key element of this 
theory. Neuman describes a normal line of defense, which is the baseline level of wellness. The 
model goes on to describe maintenance of the baseline level of wellness, as well as the lines of 
resistance that are protective mechanisms that seek to stabilize the system after an insult and 
return it to the baseline level of wellness. The theory focuses on optimal system stability and 
variations of the optimal level of wellness. It defines the return and maintenance of system 
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stability after treatment for stressor reactions as reconstitution, and emphasizes prevention as an 
important intervention. 
Neuman’s systems model can be directly applied to the physiological responses 
demonstrated by brain dead organ donors in the OR (see Appendix C). The basic survival factors 
as applied to the brain dead organ donor are organ strength or weakness. The process of brain 
death breaches the normal line of defense, as the brain can no longer participate in maintenance 
of homeostasis in the body. However, some lines of resistance remain. Neuman defines lines of 
resistance as protective mechanisms that try to stabilize the system and reestablish wellness. The 
spinal cord and lower autonomic nervous system can still discharge neural activity that can have 
visible effects such as spinal reflexes and BP changes. These BP changes in the OR could be 
viewed as a line a resistance, but with the brain not being able to participate in the feedback and 
response functions, this line of resistance BP response becomes a dysfunctional response, 
therefore it must be assisted or mitigated by intervention from the anesthetist. 
Pathophysiology of Brain Death 
Death has been defined in the U.S. through the Uniform Determination of Death Act 
(UDDA): 
[A]n individual who has sustained either (1) irreversible cessation of circulatory and 
respiratory functions, or (2) irreversible cessation of all functions of the entire brain, 
including the brain stem, is dead. A determination of death must be made in accordance 
with accepted medical standards. (National Conference of Commissioners of Uniform 
State Laws, 1980, p. 3) 
The 1968 Harvard criteria has been the traditionally accepted medical standard for the 
declaration of brain death in the U.S. It established that brain death is a permanent, irreversible 
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coma. First, the patient must be unreceptive and unresponsive to external stimuli and inner 
needs; for example, a lack of response to painful stimuli. Second, there must be no movement or 
breathing, either spontaneously or in response to stimuli, and an apnea test should be performed 
by removing the patient from mechanical ventilation for three minutes, allowing the carbon 
dioxide to rise in the body, and observing for absent respirations. Third, the patient must have 
absence of elicitable reflexes, including pupillary reflex, corneal reflex, oculovestibular reflex, 
oculocephalic reflex, gag reflex, and not exhibit any posturing, blinking, swallowing, yawning, 
vocalization, or tendon reflexes. The Harvard criteria recommend confirmation of an isoelectric 
electroencephalogram (EEG), and repeating all tests after 24 hours to ensure no change. 
Assessments and test validity require the patient not be hypothermic or have central nervous 
system (CNS) depressants obscuring the clinical picture (Harvard Medical School Ad Hoc 
Committee, 1968). 
 The most current criteria for the diagnosis of brain death are the 2010 American 
Academy of Neurology (AAN) guidelines (see Appendix A). The AAN guidelines are the most 
recent, comprehensive, evidence-based information available regarding the diagnosis of brain 
death, and aim to provide the standard for brain death diagnosis. Universal acceptance of the 
AAN guidelines for brain death diagnosis in all U.S. hospitals is still lacking. 
Brain death, as it is defined in the U.S., involves the permanent cessation of function and 
blood flow from the whole brain; however, persistence of spinal reflexes is a known, well-
documented phenomenon that occurs in some brain dead patients (Anderson & Bekker, 2015; 
McKeown et al., 2012). Spinal reflexes can be spontaneous or elicited by noxious stimuli 
(Pennefather, 1994), and reflexive activity from the spinal cord is thought to be the cause of 
intraoperative hypertension (HTN) and increased catecholamine levels (McKeown et al., 2012).  
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In brain dead patients, the herniation of the brain leads to total loss of parasympathetic activity, 
resulting in unopposed sympathetic stimulation seen as HTN and tachycardia, and is referred to 
as autonomic storm (Tuttle-Newhall, Collins, Kuo, & Schroeder, 2003).  Catecholamine release 
due to autonomic storm at the time of brain stem herniation causes organ ischemia. Systemic 
vascular resistance is elevated greater than the elevated perfusion pressure (Tuttle-Newhall et al., 
2003). After this surge comes a massive decrease in sympathetic outflow (Pratschke et al., 1999), 
causing loss of vascular tone, and therefore profound hypotension leading to cardiovascular 
collapse in many patients (Bugge, 2009).  
After brain death, although the spinal cord is not in communication with the brain, it can 
play a role in catecholamine release. Catecholamine release can be triggered via stimulation of 
the adrenal medulla, similar to spinal cord-transected, quadriplegic patients who experience 
autonomic dysreflexia, where uncontrolled sympathetic outflow is unopposed by the 
parasympathetic nervous system (Wetzel et al., 1985). Pennefather, Dark, and Bullock (1993) 
found significant hemodynamic changes in brain dead donors during organ procurement surgery 
and measured increased catecholamine levels intraoperatively. Surgical stimuli may initiate 
spinal reflexes and reflexive sympathetic discharge from the spinal cord alone. 
Incidence of Blood Pressure Derangement in Brain Death 
 According to McKeown et al. (2012), hypotension occurs 81-97% of the time in brain 
dead donors due to the loss of sympathetic tone, diabetes insipidus-related hypovolemia from 
brainstem herniation, as well as the reduced coronary blood flow and myocardial stunning from 
excessive catecholamine discharge at the time of brain death. It is important to note that Bijker et 
al. (2007) found that there is not a standard definition of intraoperative hypotension. Some 
studies define it as a decrease in systolic or MAP below an absolute threshold and others define 
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it as a decrease relative to the baseline BP. Within those definitions, the degree and duration of 
BP decrease varies as well. This variation in definitions makes it more difficult to understand the 
true incidence of intraoperative hypotension and how it is associated with adverse outcomes. 
 Wetzel et al. (1985) documented heart rate (HR) and BP changes that occurred during 
surgery for organ donation in ten brain dead donors. 
Elevations above baseline occurred within the first minute after incision and maximum 
responses were seen between five and 20 min. These peak changes in blood pressure and 
heart rate were reached before aortic cross clamping or the occurrence of any other 
surgical procedure that could be expected to mechanically elevate blood pressure or cause 
an increase in heart rate. (p. 126) 
The mean increase in systolic BP was 31 torr and diastolic pressure increased by a mean of 16 
torr. HR increased by a mean of 23 beats per minute. All donors in this study who were being 
maintained on vasopressor infusions prior to entering the OR were able to have dosages of those 
infusions decreased or stopped. Additionally, every donor demonstrated a return to baseline BP 
within 25 minutes of incision (Wetzel et al., 1985).  
Anesthesia and Hemodynamic Responses 
 The work by Wetzel et al. (1985) led to experiments to test the blunting of this 
hemodynamic response to surgical stimulus in brain dead patients. Fitzgerald et al. (2003) found 
the use of fentanyl, at a dose of seven micrograms per kilogram, was not effective in suppressing 
catecholamine release from surgical stimulation in brain dead organ donors. Serum 
catecholamine concentrations rose following noxious stimuli, however there were no differences 
in the hemodynamics in the group that received fentanyl versus the group that received the 
placebo. Investigators in this study noted that serum concentrations of epinephrine, but not 
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norepinephrine, were actually higher in the group that received fentanyl. Epinephrine levels were 
highest after sternotomy demonstrating that not only do opioids lack the ability to attenuate 
hemodynamic responses in brain dead organ donors, but also fail to mitigate the catecholamine 
discharge intraoperatively (Fitzgerald et al., 2003). 
 Antognini and Berg (1995) investigated the extent of the brain’s role in suppressing 
hemodynamic responses to noxious stimuli under isoflurane anesthesia. In this animal study, 
they were able to isolate delivery of isoflurane to the brain in one group and isolate delivery to 
the spinal cord in the other group. Those groups were compared to isoflurane delivered to the 
whole body. They found that isoflurane delivered to the whole body does prevent hemodynamic 
responses to noxious stimuli, but profoundly lowers the MAP. Furthermore, by comparing the 
brain-only and spinal cord-only groups, the researchers found that the brain has very little control 
over the hemodynamic response to noxious stimuli as the minimal alveolar concentration to 
block autonomic response (MAC-BAR) was significantly greater in the brain-only group 
compared to the MAC-BAR in the whole body group. 
 Some studies have demonstrated potential tissue protective benefits in from 
preconditioning with volatile anesthetics such as isoflurane and led to some use of volatile 
anesthetic in the brain dead donor population, but a review by De Hert, Turani, Mathur, and 
Stowe (2005) concluded that none of the studies ―unequivocally demonstrate that the use of a 
volatile anesthetic regimen resulted in a clinical benefit for the patients‖ (p. 590). 
 Several guidelines, including the 1999 recommendations from the Intensive Care Society 
of the United Kingdom (U.K.), state that anesthesia is not necessary for brain dead donor organ 
procurement operation (Morgan, Morgan, & Smith, 1999). Withholding anesthesia is the 
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standard in many places including the U.S., but it not universal and the risks and benefits of 
volatile anesthetics in brain dead donors continues to require further research. 
Boutin et al. (2012) analyzed the differences in brain dead donors in France who had 
received anesthesia versus those who had not. Anesthesia, defined as at least one dose of 
hypnotic agent, anesthetic gas, or opioid, was received by 62% of donors. Donors who did not 
receive anesthesia maintained a MAP greater than 65 mmHg more frequently than donors who 
received anesthesia. Additionally, no difference in maximum MAP was found between the two 
groups. Donors in this study who received anesthesia required more fluid challenges and 
vasopressors and exhibited higher heart rates (HRs) and lower BPs. Data from this study does 
not support the use of anesthesia to control intraoperative HTN. 
Management of Hypertension 
 Some have argued that volatile anesthetics can and should be used in brain dead organ 
donors to control intraoperative HTN; however, evidence is lacking (Boutin et al., 2012). The 
1999 recommendations from the Intensive Care Society in the U.K. state that although anesthesia 
is not necessary for brain dead organ donors, volatile agents can be used to manage HTN 
(Morgan et al., 1999). Available evidence suggests volatile anesthetics are a greater detriment 
than potential benefit due to the lowering of BP and therefore decreased end organ perfusion. 
 Intraoperative HTN can be transient due to increases in catecholamines from sympathetic 
stimulation, thus most recommendations for treatment of HTN in brain dead organ donors 
suggest administering short-acting agents to control HTN. The risk of organ damage with HTN 
occurs when the BP exceeds the upper limit of autoregulation. Powner, Darby, and Kellum 
(2004) recommend conservative treatment of HTN. Initial HTN interventions should include 
decreasing or stopping vasopressor infusions. They suggest initiation of antihypertensive therapy 
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after MAP has been greater than 95 mmHg for 30 minutes, with a goal of MAP less than 90 
mmHg, but above 65-70 mmHg. Additionally, the authors recommend labetalol 20 milligrams 
IV bolus every 20 minutes times two doses titrated to the goals above. If MAP is still not within 
the goal parameters, a nicardipine infusion is recommended starting at five milligrams per hour 
and titrated for the goals above, up to a maximum infusion rate of 15 milligrams per hour. 
 Although Anderson et al. (2015), acknowledges HTN related to autonomic storm can be 
managed with nitroprusside or esmolol, they state that autonomic storm during brain herniation 
is not an issue in the OR after time has elapsed since herniation, diagnosis of brain death, and 
consent for donation. The authors fail to address anesthetic management of HTN intraoperatively 
in their narrative review of anesthetic considerations in organ procurement surgery. 
 Likewise, Arbour (2005) also recommends treating autonomic storm with esmolol and 
nitroprusside. Most donor management literature focuses on interventions during and after brain 
death declaration in the ICU and neglects the intraoperative phase. Donor management 
guidelines for the ICU can be extrapolated to the OR; however, it can be argued that the 
physiology issues present when treating autonomic storm at the time of brain death differ from 
the physiology issues of treatment of intraoperative HTN in the brain dead organ donor. The 
principles of choosing drugs with short onset and duration as well as ability to titrate (Arbour, 
2005) may be helpful in either situation. 
Management of Hypotension 
 More studies are available regarding management of hypotension in brain dead donors 
compared with management of HTN. The literature is heavily focused on the ICU management 
rather than intraoperative management, but significant crossover exists. Literature pertaining to 
fluid management goals in the ICU, hormone replacement protocols, and corticosteroids were 
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not included in this review as those interventions are typically completed during donor 
management in the ICU. Proper fluid resuscitation to euvolemia is the standard for organ 
procurements, and without adequate fluid resuscitation, intraoperative management options may 
be less successful.  
Traditionally, cerebral blood flow autoregulation between a MAP of 60 and 160 mmHg 
has been used a benchmark for intraoperative BP management, with the knowledge that things 
like chronic HTN can shift this curve. Most tissues in the body are able to autoregulate blood 
flow to some extent (Butterworth, Mackey, & Wasnick, 2013). Ono et al. (2013) found that acute 
kidney injury was independently associated with excursions of MAP below the lower limit of 
cerebral blood flow autoregulation. Additionally, Rhee et al. (2012) found that renal blood flow 
decreased incrementally below baseline perfusion pressure much earlier than cerebral blood flow 
decreased in the setting of hemorrhagic shock. Failure to correct hypotension can lead to acute 
kidney injury (Lange & Souter, 2015). 
 Hemodynamic management should focus on the goals of restoring euvolemia, 
maintaining adequate perfusion pressure, and optimizing cardiac output (Lange & Souter, 2015). 
Literature reviewed recommended maintaining hemodynamic stability with a goal of a MAP of 
60-90 mmHg.  
When hemodynamic instability in the brain-dead donor is not corrected, kidney 
dysfunction is enhanced and immune activation occurs faster and is more profound. The 
observed changes may predispose the graft for additional ischemia/reperfusion injury 
during the transplant process and hence accelerate rejection of the graft after 
transplantation. (van der Hoeven et al., 2003, p. 1874)  
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Additionally, van der Hoeven, et al. (2000) states that progressive liver dysfunction is 
significantly worse in rats that were hemodynamically unstable (defined as MAPs of 55  5.3 
mmHg one hour after brain death and 52  9.9 mmHg six hours after brain death) with increased 
immune activation also being present in these situations. 
After proper fluid resuscitation, if MAP is less than 65 mmHg, dopamine has 
traditionally been the first-line vasopressor recommended for management of hypotension in 
brain dead organ donors (Bugge, 2009). Dopamine may offer protective effects against ischemia-
reperfusion injuries and inflammation by enzyme induction of heme-oxygenase-1 and other 
enzymes. Bugge (2009) found that catecholamine use in donors may have some benefit in four-
year graft survival rates for kidney transplantation. Norepinephrine increased the incidence of 
initial non-function in heart recipients, but did not negatively affect liver grafts. The author notes 
that the study was retrospective therefore causality could not be determined. Bugge (2009) also 
indicates use and avoidance of specific vasoactive medications in donors are varied and lack 
evidentiary consensus, as there is a lack of randomized controlled trials. 
Mukadem et al. (2005) demonstrated catecholamine use (defined in this study as 
dopamine at 2.5 mcg/kg/min or greater, epinephrine, or norepinephrine) was associated with 
worsening gas exchange after lung transplantation. Zaroff et al. (2002) proposed a strict protocol 
for limiting the maximum dosages of catecholamines in brain dead donors in order to facilitate 
better outcomes for heart transplants as high-dose catecholamine infusions have been thought to 
cause downregulation of beta adrenergic receptors, depletion of norepinephrine and high-energy 
phosphates in the myocardium. Silva et al. (2002) found that primary graft failure for heart 
transplants was not increased in when donors had been maintained on high-dose catecholamine 
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infusions in order to maintain a MAP 70-100 mmHg, suggesting that organ perfusion pressure is 
important than adherence to maximum suggested dosages. 
Studies have shown successful hemodynamic management with both norepinephrine and 
vasopressin after adequate fluid resuscitation and dopamine infusion (Bugge, 2009). Practice of 
vasopressor management varies widely since there is a lack of evidence to recommend use or 
avoidance of any one vasopressor over another other than based on clinical presentation of the 
donor (Westphal et al., 2012). 
Studies establishing and examining the BP alterations encountered in brain dead donors 
during organ procurement are decades old. This study provides an update on intraoperative BP 
derangements in brain dead organ donors. Additionally, much of the available evidence to 
potentially support the argument for use of volatile anesthetics in brain dead organ donors is 
extrapolated from animal studies. This pilot study examines the effects of volatile anesthetics on 
BP during procurement surgery for brain dead organ donors. 
The evidence table (Table 1) provides a summative overview of the main studies 
reviewed in the literature review section regarding the available evidence about the 
intraoperative blood pressure variations and the effects of anesthesia in brain dead organ donors. 
Methods 
Research Design 
 This study employed a retrospective chart review to analyze intraoperative BP 
management of brain dead organ donors. MAPs were collected every minute. Presence or 
absence of the administration of volatile anesthetic gas in the OR was collected.  Type of volatile 
anesthetic administered and end-tidal concentrations of the volatile anesthetic gas were also 
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collected. The study was designed to examine intraoperative hemodynamic stability and further 
investigate the effects of volatiles anesthetic gas on brain dead donors during organ procurement. 
Sampling and Setting 
 Institutional review board (IRB) approval from both DePaul University as well as 
Advocate Christ Medical Center (ACMC) was obtained prior to data collection. Standard Health 
Insurance Portability and Accountability Act (HIPAA) regulations were followed to protect 
donor and donor family anonymity as described later in the data collection section. Intraoperative 
records were reviewed from organ donor procurement surgeries from May 1, 2015 through April 
30, 2016 at ACMC, in Oak Lawn, Illinois. This yielded 28 individual cases. 
 ACMC is a level one trauma center in the near southwest suburbs of Chicago. This 
facility has been the focus of media attention in recent years due to the high volume of traumas 
and the high rates of violence in certain parts of Chicago. ACMC was chosen as the study site 
because it regularly encounters a high number of organ donors. 
Study 
Inclusion criteria 
 All brain dead organ donors age 15 and older who reached the OR at ACMC between May 1, 
2015 through April 30, 2016 
 Exclusion criteria 
 Donations after cardiac death 
 Donors that cardiac arrest prior to reaching the OR and therefore no organs are procured 
 Brain dead organ donors age 14 and under 
Instruments for Data Collection 
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 Data was collected from the intraoperative records at ACMC which used the Cerner 
SurgiNet charting system at the time of this study. BPs were automatically saved to the 
intraoperative anesthesia record from the patient monitor. The standard procedure for BP 
monitoring for brain dead organ donors at ACMC and by the local OPO is to monitor BPs from 
an existing arterial line, typically placed in the femoral artery. MAPs recorded for this study 
were taken from the arterial line pressure at one minute intervals and automatic BP cuff readings 
when available. Data collected includes: 
 MAPs documented in the anesthesia record at one minute intervals 
 Total number of minutes in the OR (defined as starting at first recorded BP to last 
recorded BP before aortic cross clamp) 
 Administration and end-tidal concentrations of volatile anesthetic gas such as 
sevoflurane, isoflurane, and desflurane 
Ethical Considerations 
Federal regulation 45 C.F.R. §46.102 (US Department of Health and Human Services, 
2009) defines a human subject as a "living individual about whom an investigator (whether 
professional or student) conducting research obtains (1) Data through intervention or interaction 
with the individual, or (2) Identifiable private information" (p.4). Research involving deceased 
human subjects does not meet the criteria for research with human subjects according to the law. 
Patients who are declared brain dead meet the medical and legal criteria for death. 
Although the subjects in this study do not meet the criteria for human subjects, it was still 
essential to protect their private health information. The medical record numbers (MRNs) were 
the initial identifiers of the cases to determine if the donor met inclusion criteria for this study. 
This information was protected as described below in the data collection section. Sensitive 
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details surrounding the medical history and manner of death were not included in this chart 
review. No identifiable information, such as the date of the surgery, age, or date of birth was 
recorded for this study. 
Data Collection 
The data gathered in this chart review included MAP BP readings, as well as use of 
volatile anesthetic gas and their end-tidal concentrations. Patients should not be able to be 
identified from this information; however, patients were initially be identified by MRN by the 
medical records department at ACMC. One Excel spreadsheet was made with the MRN and 
assigned subject number without any other potential patient identifier. The data sheet was stored 
in a password protected spreadsheet on a password protected laptop computer that is locked in a 
safe in the primary investigator’s (Alison Karmanian) home office when unattended. A second 
Excel spreadsheet was used to store the data collected on MAPs and volatile anesthetic gas with 
only the subject number identifying the patient. The data collection spreadsheet did not have any 
information that could identify the subject and consisted of gathering data that already existed; 
therefore, the study was exempt from the Common Rule (US Department of Health and Human 
Services, 2009). The MRN, nor any other identifiable patient information, was not disseminated 
to committee members or included in the study and report in compliance with HIPPA rules. 
Results 
Twenty-eight cases met the inclusion criteria, and data was analyzed using International 
Business Machines (IBM) SPSS version 24 (IBM, 2017). Statistical significance was set 
at p value of ≤ 0.05 for all inferential statistics. 
Mean MAP was calculated for each donor. Mean MAPs ranged from 61.04 to 99.34 
mmHg with a mean of M= 84.51 mmHg (Figure 1). Twenty-two donors (78.6%) received 
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volatile anesthetic gas at some point in the anesthesia record. Six donors (21.4%) received no 
volatile anesthetic gas. Mean end-tidal concentrations of volatile anesthetic gas in the 22 donors 
who received volatile anesthetic gas ranged from 0 to 1.25% with a mean end-tidal concentration 
of M= 0.39% (Figure 2). Sevoflurane was used in 17 donors, and isoflurane was used in 5 
donors. 
Mean MAP in donors that did not receive volatile anesthetic gas was M= 78.49 mmHg 
(SD= 9.78 mmHg). Mean MAP in donors that received volatile anesthetic gas was M= 86.16 
mmHg (SD= 7.02 mmHg). Equal variances of the groups were examined using the Levene’s test, 
and revealed homogeneity. Independent sample t test revealed a statistically significant 
difference between mean MAPs of the two groups (t= 2.182, p= 0.038). 
The Spearman’s rho correlation coefficient (rs) was used to determine the relationship 
between mean MAP and mean end-tidal concentration of volatile anesthetic gas in donors in this 
study because mean end-tidal concentrations were not normally distributed. There was no 
statistical significance (p=0.414) found for the weak negative linear correlation (rs= -0.184) 
between mean end-tidal concentration and mean MAP. 
Discussion 
 This single-center pilot study at a large teaching hospital and transplant center that 
performs a high volume of organ donors was conducted to determine mean MAP and duration of 
intraoperative hypotension during organ procurement operations. Available literature on 
recommendations for MAP goals in organ donors suggest that a MAP between 60-90 mmHg is 
optimal (Kotloff et al., 2015, McKeown et al., 2012, Powner, 2005, Powner et al., 
2004,Westphal et al., 2012, Zaroff et al., 2001). Mean MAPs for donors in this study during the 
organ procurement operation ranged from 61.04 to 99.34 mmHg with a mean of 84.51 mmHg. 
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On average, BP of donors was managed in a way that MAPs fell within this optimal range. In the 
28 donors included in this study, no donor demonstrated an average MAP below 60 mmHg. Five 
donors did have an average MAP greater than 90 mmHg, indicating that intraoperative 
hypertension is a more prevalent problem than intraoperative hypotension. 
The majority of donors (22 out of 28, or 78.6%) in the study received volatile anesthetic 
gas at some point during the organ procurement. Available literature states that anesthetics, such 
as volatile anesthetic gas, are not necessary for this procedure as donors are brain dead (Boutin et 
al., 2012, Morgan et al., 1999). It was found in this study that administration of volatile 
anesthetic gas during organ procurement is a very common occurrence at this medical center. 
Although published data and rationale on using volatile anesthetic gas in this population is 
limited, the rationale of blocking sympathetic blood pressure response to incision is commonly 
cited (Antognini & Berg, 1995, Elkins, 2010, Yoo et al., 2008, Young & Matta, 2000). The 
clinical dose of volatile anesthetic gas needed to suppress this response in 50% of patients is 
referred to at the minimum alveolar concentration to block adrenergic response (MAC-BAR) 
(Barash et al., 2013). MAC-BAR is estimated at 50% higher than minimum alveolar 
concentration (MAC) (Barash et al., 2013). The MAC of sevoflurane is 1.8% end-tidal 
concentration, and the MAC of isoflurane is 1.17%, which makes MAC-BAR for sevoflurane 
2.7% and MAC-BAR for isoflurane 1.76%. The highest mean end-tidal concentration of volatile 
anesthetic gas for a donor in this study was 1.25% which falls well below MAC-BAR for either 
volatile anesthetic gas used in this study (sevoflurane was used in 17 donors, and isoflurane was 
used in 5 donors). 
Mean MAP was higher in donors who received volatile anesthetic gas (86.16 mmHg  
7.02 mmHg) than in donors who did not receive it (78.49 mmHg  9.78). Volatile anesthetic 
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gases all share a common side effect of causing dose-dependent hypotension via peripheral 
vasodilation (Barash et al., 2013). Therefore, it would be natural to expect donors who received 
volatile anesthetic gas to display lower mean MAPs, but this is not what was found in this study. 
It could be inferred that volatile anesthetic gas was being used to assist in controlling BP in 
donors who exhibited high BP intraoperatively during procurements. Volatile anesthetic gas is 
very convenient and easy to start, stop, and titrate, and anesthesia providers are likely most 
comfortable with this method of augmenting high blood pressure as this is often a first-line agent 
used for controlling an increasing BP in the operating room for most standard surgical cases. 
An independent samples t test between donors who received volatile anesthetic and those 
who did not determined that the difference in mean MAPs between the two groups was 
statistically significant (p= 0.038). 
The Spearman correlation coefficient (rs) was also performed and determined that there 
the weak negative relationship between mean MAP and end-tidal concentration of anesthetic gas 
was not statistically significant. Interestingly, as noted above, low means were more related to 
low end-tidal concentrations of volatile anesthetic gas, contrary to what the literature states about 
the dose-dependent hypotensive effects of volatile anesthetic gas. This seems to indicate that 
anesthesia providers may be implementing use of volatile anesthetic gas more in donors that are 
demonstrating intraoperative HTN than those who are not. 
Other medications that affect BP were not recorded as part of this study which poses a 
significant limitation. Due to the physiological processes that occur during and after brain death, 
vasopressor support with infusions is common. Additionally, anesthesia providers commonly 
administer intravenous boluses of vasopressors to titrate BP to ideal levels. Antihypertensive 
agents could also be administered in the operating room and would confound the BP variability. 
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In addition to use of these infusions and boluses of medications that can alter BP, availability of 
this information in the electronic anesthesia medical record is dependent on the user accurately 
recording the drug, dose, and time of administration. In the future, smart pumps and medication 
scanning in the operating room may help improve the accuracy of medication administration 
intraoperatively. 
The MAP and end-tidal concentrations of volatile anesthetic gas are automatically 
recorded from the equipment directly in the electronic anesthesia record. In this specific 
electronic anesthesia record system, this data is able to be changed by the user in a different 
screen. Additionally, aberrant readings from the arterial line which records the blood pressure 
may be automatically documented on the record (such as when blood is being drawn from the 
line or when the line is being flushed). The transducer of the arterial line must be calibrated 
correctly in order to obtain accurate readings of arterial BP. There is not a way to verify that this 
was done in the cases examined for this retrospective chart review. When recordings from the 
arterial line were not available in the anesthesia record, non-invasive blood pressure cuff MAP 
values were used instead. If systolic BP and diastolic BP were documented in the record, but the 
MAP value was not present or was clearly aberrant (greater that the systolic BP value), MAP 
was calculated by the primary investigator of the study. 
During data collection, different patterns of volatile gas administrations were observed 
including the use of volatile anesthetic gas only around incision time, as needed, throughout the 
entire procedure, choice of volatile anesthetic gas (sevoflurane and isoflurane were both used), 
and use of no volatile anesthetic gas. Provider preference may have an impact on the use of 
anesthetic gas and potentially the pattern of use, but the anesthesia providers for the cases were 
not recorded as part of this study. 
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Several other details may impact the intraoperative blood pressure of brain dead organ 
donors including medical conditions such as cardiogenic shock or supportive therapies such as 
intra-aortic balloon pumps or extracorporeal membrane oxygenation, co-morbidities, age, and 
cause of death. With only 28 donors identified for this study, collection of any of the above 
information could potentially identify a particular donor and therefore, these details were 
deliberately excluded from data collection, despite their potential significance. 
Patients were identified for this study through the billing department of the hospital 
which keeps a log of all organ donor cases. Identification of appropriate candidates was entirely 
dependent on the accuracy of this list. 
Additional intraoperative event time would be helpful to collect in future studies 
including incision time, sternotomy time, and aortic cross-clamp time. 
Future studies should be done comparing recipient outcome data to intraoperative BP and 
the use of volatile anesthetic gas. More detailed data may be able to determine which organs may 
be more sensitive to the effects of low or high BP during organ procurement and may provide 
some insight on autoregulation of blood flow to organs in brain dead patients. Future prospective 
studies may benefit from observation and data collection of vital signs and medication 
administration in real time to minimize documentation errors. 
Conclusion 
 This retrospective review of records among brain dead organ donors aged 15 and older 
demonstrated that intraoperative HTN is more prevalent than intraoperative hypotension. 
Volatile anesthetic gas is often being used at this medical center during organ procurements at 
relatively low concentrations. There was a statistically significant difference (p= 0.038) between 
mean MAPs in donors who received volatile anesthetic gas versus those who did not, and there 
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was no significant relationship found between mean MAP and end-tidal concentration of volatile 
anesthetic gas.  
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Table 1 
 Evidence-based Table on the Intraoperative Blood Pressure and Effect of Volatile Anesthetic in 
Brain Dead Organ Donors 
Author/ 
Year 
Design/ 
Method/ 
Sample/ 
Setting 
Key Findings Appraisal Relevant 
to the DNP Project 
Bugge (2009) 
 
Review -sustained hypotension associated with 
impaired graft function 
-80-90% require vasopressor or inotropic 
support 
-vasoactive medication use not based on 
randomized controlled trials; widely 
divergent opinions on best to use and avoid 
-adequate coronary perfusion pressure may 
be more important than avoiding high-dose 
catecholamines 
-dopamine is traditional first choice pressor 
-dopamine may induce protective enzymes 
(HO-1) to guard against ischemia/ 
reperfusion injury and inflammation 
-dopamine maximum of 10 mcg/kg/min 
lacks good evidence 
-dopamine should be titrated to target 
hemodynamic effect (due to individual 
differences in pharmacodynamics) with the 
limitation of tachycardia  
-after fluid resuscitation and dopamine, 
both norepinephrine and vasopressin have 
been used successfully 
-vasopressin good for DI and decreases 
catecholamine use 
-norepinephrine in mammals increases 
coronary and RBF 
-norepinephrine is related to primary graft 
dysfunction and decreased right ventricle 
contraction and 1-year survival for heart 
transplant (retrospective, therefore not 
causal) 
-volatile anesthetics still experimental, but 
may protect heart from ischemia/ 
reperfusion injury 
-review evaluates current 
practice against current 
research 
-HD management plan 
describes order of 
interventions and 
discusses HD monitoring 
options 
Mukadam et al. 
(2005)  
Retrospectively 
analyzed, 
prospectively 
collected data of 
60 lung donors 
and recipients; 
categorized to 
treatment or 
-catecholamine use was associated with 
worse gas exchange after transplantation- 
difference not related to ischemic time, 
preservation technique, or recipient donor 
-donors requiring catecholamines may have 
had more severe AS and therefore more 
pulmonary injury and inflammation. 
-if catecholamines were needed for CV 
-different organs respond 
differently to 
catecholamines with 
some gaining protection 
and others demonstrating 
worsened outcomes- a 
balance that must be 
struck with donor 
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control group by 
what they 
received and 
compared PaO2/ 
FiO2 ratios 
function, it could exacerbate left atrial 
pressure 
management 
Boutin et al. 
(2012)  
Multicenter 
retrospective 
study of records 
of BD patients; 
data collected 
includes 
extended criteria 
donor status, 
resuscitation 
duration and 
procedures, 
period of brain 
death, cold 
ischemic time, 
type of 
anesthesia, 
hemodynamic 
and ventilatory 
parameters, and 
impact of 
anesthesia on 
renal graft 
-62% of donors in study received anesthesia 
-donors who did not receive anesthesia 
maintained a MAP >65 more frequently 
with no difference in maximum MAP 
-those who received anesthesia required 
more fluid challenges, (especially with 
colloids) and pressors, had lower MAPs and 
higher HRs 
-persistence of partial spinal regulation in 
BP and temperature 
-reports increased HR and BP in 24% of 
subjects who received no anesthesia 
-tissue protective effects of opioids are not 
justified by research, and there is very 
limited info on the tissue protective effects 
of volatile anesthetic agents 
-anesthesia  
hypotension  poor graft 
function 
-anesthesia showed no 
difference in maximum 
MAP 
-the use of anesthesia to 
control intraoperative 
HTN is not supported  by 
the data in this study 
-anesthesia increases 
incidence of  hypotension 
and does not control HTN 
Young and 
Matta (2000)  
Expert opinion -different definitions of brain death in 
different countries (whole brain versus 
brain stem) 
-Intensive Care Society of U.K. 1999 
recommendations say anesthesia not 
necessary for BD donors, but HTN can be 
managed with nitroprusside or a volatile 
agent 
-argues for anesthesia for hemodynamic 
response to surgery and persistence of 
higher brain & spinal cord function in some 
donors & inability to test reticular 
formation 
-different definitions may 
impact physiology and 
therefore donor 
management, so 
management 
recommendations cannot 
necessarily be generalized 
to the international 
community 
Kotloff et al. 
(2015)  
Consensus 
statement; 
multidisciplinary
, multi-
institutional task 
force divided in 
subcommittees; 
available 
literature 
comprised of 
mainly 
observational 
studies and case 
series (low 
quality evidence) 
-HD management recommendations: 
 hypovolemia frequently present at BD 
and should be corrected quickly 
 HD monitoring tools are helpful in 
assessment of volume status and response 
to therapy. 
 PAC, CVC, or noninvasive monitors 
should be considered for serial & 
continuous measurement 
-fluid resuscitation guidelines: MAP ≥60, 
UO ≥1cc/kg/hr, EF at least 45%, lower 
vasopressor dose (e.g. dopamine ≤ 
10mcg/kg/min) 
-goal directed fluid therapy with goal of 
euvolemia recommended for entire 
-their literature review 
revealed low quality 
evidence therefore paper 
is termed consensus 
statement versus 
guidelines 
-ICU recommendations 
can likely be extrapolated 
to OR management 
-euvolemia 
-specific parameters for 
goal-directed therapy and 
recommendations for HD 
monitoring 
-use of vasopressin 
associated with increased 
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management phase 
-HES should not be routinely used due to 
issues with AKI, coagulopathy, trapping in 
hepatic reticuloendothelial system, and is 
associated with delay graft function/ failure 
-low molecular weight HES may be safer, 
but not currently recommended 
-crystalloid & colloids ok 
 -dopamine is the traditional first-line 
vasoactive agent; insufficient data to 
recommend others over dopamine 
-dopamine has protective effects  
-vasopressin is alternate 1
st
 line agent; 
additional pressor for refractory shock 
-norepinephrine, phenylephrine, and others 
may be used in severe shock (dobutamine, 
dopamine, and epinephrine for primary 
pump dysfunction; norepinephrine and 
phenylephrine for vasodilatory shock/low 
SVR) 
-if HD goals still unmet and/or EF <45%, 
HRT is recommended 
rate of organ recovery 
-recommendations for 
which vasoactives for 
which scenarios 
 
 
Barash et al. 
(2013) 
Textbook -BD donors present many challenging 
management issues because collected 
experience in a single center is usually 
small, and research in brain-dead human 
subjects is sparse 
-there is solid evidence that desmopressin is 
better than norepinephrine for maintaining 
quality of donor hearts 
-mainstay of donor management is 
maintenance of euvolemia; CVP monitoring 
standard (maintained 6-12); PCWP <12 
when PAC used 
-goals of volume resuscitation and HR are 
to minimize pressors as high-dose 
dopamine associated with renal graft failure 
-vasopressin better than 
norepinephrine for hearts 
-CVP 6-12 
-POAP when available 
<12 
-goal: minimize use of 
pressors  balance good 
end-organ perfusion by 
using pressors only when 
necessary to minimize 
deleterious effects 
Anderson et al. 
(2015) 
Narrative review -intraoperative management may affect 
recipient outcomes 
-dramatic loss of sympathetic tone can 
result in HDI 
-evaporative loss 
-incisional blood loss 
-polyuria secondary to DI 
-AS not encountered in OR, but managed 
with nitroprusside and esmolol 
-avoid HES 
-arterial pulse pressure variation can guide 
fluid therapy 
-if lung procurement, colloid preferred 
-dopamine 5 mcg/kg/min 
improves blood flow to 
renal, mesenteric, and 
coronary vascular beds  
enhances organ perfusion  
-dopamine versus 
norepinephrine; evidence 
lacks superiority of one 
over the other 
-avoid high-dose alpha 
agonists  decreased 
blood flow and O2 
delivery 
McKeown et al. 
(2012) 
Review -increasing consensus in donor management 
guidelines, but lacking controlled 
evaluation of many of the specific 
components of donor management 
-optimal treatment combinations not 
established and more research needed 
-hormonal resuscitation 
as discussed in the UNOS 
critical pathway for the 
organ donor in 1999 
showed a 1% increase in 
organs retrieved from BD 
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-incidence of hypotension in donors: 81-
97% 
-Crystal City Consensus Conference 
Cardiac Recommendations 
-Canadian multidisciplinary forum on donor 
management: HR 60-120, SBP >100, 
MAP≥70 
-rule of 100s (SBP, UO, PaO2, Hgb) 
-vasopressin 0.5-2.4 units/hr may decrease 
catecholamine requirements 
-high-dose norepinephrine 
(>0.05mcg/kg/min) should be avoided if 
possible 
-multicenter clinical trial underway to 
determine if fluid management protocol via 
pulse-pressure variation can increase 
viability of lungs and other organs 
-vasopressin recommended as 1
st
 line agent 
by Canadian guidelines 
-HR looked good when initial studies were 
compared to historic controls, but 
randomized studies failed to show benefit 
-in one study, untransplantable hearts were 
resuscitated during surgery and improved 
-CV response is generated and modifiable 
at the level of the spinal cord alone 
-spinal reflexes can occur spontaneously or 
with surgical stimulus  NMB 
-surgical manipulations can cause CV 
instability 
-several randomized donor intervention 
studies are in progress 
donors, but a 19.5% 
increase in hearts 
transplanted 
- pilot study donors were 
younger and less likely to 
have had strokes and 
other comorbidities; more 
data needed 
 
Elkins (2010)  Literature review -treatment of AS with emolol, nicardipine, 
and urapidil in 2006 study 
-Arbour (2005) recommends esmolol and 
nitroprusside as effective and short-acting 
agents for HTN 
-BD causes decreased CO and increased 
SVR 
-thyroid supplementation improved CO and 
SVR  increased tissue perfusion & 
oxygenation; decreased lactic acidosis 
-CV stimulation is believed to involve a 
reflex arc to the adrenal medulla and may 
be increased by excitation of spinal cord 
below the lesion 
-1.5% isoflurane 20 minutes prior to 
ischemia (animal study by Hashiguchi et al. 
(2005)); significantly lower BUN and 
creatinine at 24 and 48 hours after 
transplantation/ reperfusion 
-isoflurane, xenon, nitrous oxide at 0.43% 
MAC suppress effects of TNF-α on certain 
gene and protein expression that can 
damage endothelium 
-pathophysiology similar 
to autonomic dysreflexia; 
uncontrolled sympathetic 
outflow 
-catecholamines trigger 
inflammatory response 
and ischemia  acute 
rejection 
-more research needed on 
ischemic preconditioning 
in donors 
- literature suggests 
strongly that AS causes 
deterioration of organs, 
therefore preventing 
sympathetic surge 
intraoperatively due to 
surgical stimulation could 
increase likelihood of 
successful transplant 
Fitzgerald et al. Randomized, -use of fentanyl 7 mcg/kg was not effective -opioids have shown to 
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(2003) 
 
placebo-
controlled, 
double-blinded 
study (n=17) 
in suppressing the catecholamine release, 
following painful surgical stimulation in 
BD organ donors 
-catecholamine concentrations rose 
following painful stimuli 
-no differences in hemodynamics between 
the fentanyl and the placebo group 
-epinephrine concentrations, but not 
norepinephrine, were higher in the fentanyl 
group, reaching significance following 
sternotomy 
not be effective in 
preventing catecholamine 
release or maintaining BP 
control 
Wetzel et al. 
(1985) 
 
Retrospective 
chart review of 
10 donors 
-SBP increased by a mean of 31 mmHg, 
DBP  by 16mmHg, and HR by 23 bpm in 
response to surgical stimulation 
-there is significant HD 
response to surgical 
stimuli in BD patients 
Antognini and 
Berg (1995) 
 
Quasi-
experimental 
(group I 
isoflurane to 
torso, group II 
isoflurane to 
cranial, whole-
body 
administration of 
isoflurane) 
-theorized that during isoflurane anesthesia, 
CV responses to noxious stimuli were 
generated in the spinal cord 
-at ~1 MAC, MAP changes for Group II 
were much smaller than MAP for the 
whole-body 
-for whole-body administration of 
isoflurane, MAP change was 42  20 
mmHg for MAC values at 1.0  0.1 
-MAP change for Group II was 12  9 
mmHg at 1.1  0.4 MAC 
-there was decreased response in MAP to 
the noxious stimulus in Group II, 
suggesting an inhibitory response 
-isoflurane suppressed BP 
response to noxious 
stimuli, but this also 
resulted in hypotension 
-MAC-BAR for brain 
only isoflurane group 
substantially exceeded 
MAC-BAR for the 
whole-body group 
-brain only anesthesia 
group exhibited 
spontaneous movement 
with noxious stimuli 
-whole-body 
administration of 
isoflurane inhibits CV 
responses to noxious 
stimuli, but causes a 
substantial decrease in 
MAP 
Powner (2005) 
 
Review -goal: maintenance of MAP > 60 
-there is little evidenced-based data that ties 
specific hemodynamic variables with 
outcomes after heart transplant 
-successful titration of 
preload, afterload, HR, 
and contractility achieves 
optimal cardiac 
performance 
Powner et al. 
(2004) 
Guidelines 
synthesized from 
articles in 
Progress in 
Transplantation 
that outlined 
treatment issues 
in donor care 
-HTN: conservative treatment 
recommendations; goal: MAP <90, but 
>65-70 
-therapy should start at MAP>95 x 30 
minutes or more 
-hypotension (MAP<60): different kinds of 
shock; in BD, loss of vasomotor centers in 
brain  vasodilation; decreased cardiac 
contractility; hypovolemia due to DI; 
treatment goal: MAP 65-75 
-concrete parameters and 
recommendations for HD 
normal values and 
treatment 
-specific drug 
recommendations 
Zaroff et al. 
(2001) 
 
Consensus 
statement/ expert 
opinion 
-adjust inotropes to maintain MAP ≥60 
-target dopamine or dobutamine  < 
10mcg/kg/min 
-norepinephrine and 
epinephrine should be 
tapered off rapidly in 
favor of dopamine and 
dobutamine 
Van der 
Hoeven et al. 
Randomized 
controlled trial 
-the hypotensive group remained 
hypotensive after brain death with MAP 55 
-dysfunction of the 
potential donor liver can 
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(2000) 
 
 5.3 after 1 hour and 52  9.9 after 6 hours 
- Cited Koo et al. (1999) who found similar 
activation of adhesion molecules in human 
cadaveric kidneys before reperfusion 
be reduced to some extent 
by maintaining 
normotension 
-both progressive liver 
dysfunction & infiltration 
of neutrophils can cause 
increased 
immunogenicity of the 
potential donor organ, 
decreased organ viability, 
& increased primary graft 
dysfunction, acute 
rejection, and lower graft 
survival rates 
Pratschke et al. 
(1999) 
 
Peer-reviewed, 
published 
overview 
-early HTN phase and late normotensive or 
hypotensive phase (loss of autonomic tone) 
-both initial and late 
circulatory changes can 
cause severe ischemic 
damage and worsen 
transplant outcomes 
-both the ischemia and 
the reperfusion cause 
tissue injury 
-brain dead organs have 
higher immunogenicity 
than living donors (if both 
are normotensive) 
-ischemic insults 
happening near the time 
of organ transplantation 
are risk factors for late 
failure for the transplant 
Tuttle-Newhall 
et al. (2003) 
Monograph -causes of HDI: hypovolemia (trauma or 
DI), decreased vascular tone, myocardial 
depression 
-clinical experience has demonstrated that 
normalization of HD parameters with 
volume replacement, inotropes, and careful 
administration of vasoconstrictors is 
associated with good transplant outcomes 
(immediate allograft function) 
-BD terminates PNS activity resulting in 
unopposed SNS stimulation (autonomic 
storm) 
-loss of baroreceptor function causes 
uncoupling of ANS and CV function 
causing the subsequent normotensive or 
hypotensive state 
-unopposed vasodilation and impaired 
myocardial function (injury during 
autonomic storm and severe catecholamine 
depletion) 
-α agonist may be appropriate due to low 
SVR resulting from sympathectomy, but 
should be avoided whenever possible 
-HDI in the donor can 
cause organ dysfunction 
after transplantation 
-increased vascular 
resistance that exceed  
perfusion pressure  causes 
end organ ischemia in rats 
(Herijgers et al., 1996)  
-recommends pressor 
therapy guided by PAC or 
TEE 
Pennefather, 
Dark, and 
Prospective 
observational 
-dopamine can cause potentially harmful 
decrease in hepatic mitochondrial redox 
-procurement causes 
significant HD changes 
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Bullock (1993) 
 
study in 14 brain 
dead patients (10 
thoracic/ 
abdominal 
donors and 4 
abdominal only 
donors) 
state and renal function in recipient can be 
impaired by high-dose dopamine in donor 
-serial plasma catecholamine concentrations 
measured in donors who did not receive 
dopamine (could not measure due to 
interference when dopamine was used- 9 
patients) 
-consistent biphasic response in 1
st
 30 
minutes: early increase in SVR and PAWP 
-by 30 minutes, SVR, PVR, MAP, PAWP, 
and CVP decrease, and HR and CI increase 
-two patients suffered a precipitous drop in 
SVR and PAWP likely due to dilation 
which caused significant decrease in CI and 
MAP- IVF bolus restored CI and MAP in 
both patients 
-intermittent surgical manipulation affected 
accuracy of HD measurements 
-increased SVR and PAWP at 30 minutes 
and before thoracotomy suggests increased 
myocardial contractility perhaps due to 
endogenous catecholamines 
-vasoconstriction theories: spinal 
vasoconstrictor reflex, reflex spinal 
stimulation of adrenal medulla, residual 
brain stem function (U.K. study- not whole 
brain death declaration model) 
-vasodilation theory: late decrease in SVR 
due to vasodilation from epinephrine 
secretion 
that may alter organ 
perfusion 
-organ perfusion may be 
impaired by inotropes 
-suggests using PAC to 
minimize use of inotropes 
Rhee et al. 
(2012) 
 
Observational 
study- animals 
-renovascular autoregulation can be 
monitored using the renovascular reactivity 
index (RVx) 
-autoregulation is mediated by vascular 
reactivity, which is defined by Lee et al. 
(2009) as low-frequency diameter changes 
in resistance vessels in response to changes 
in ABP 
RBF decrease 
from baseline 
Perfusion 
pressure 
75% 60 
50% 45 
25% 40 
 
CBF decrease 
from baseline 
Perfusion 
pressure 
75% 30 
50% 25 
25% 15 
 
-renovascular 
autoregulation, as 
measured by RVx, is 
impaired before cerebral 
autoregulation during 
shock in piglets 
-BP does not necessarily 
indicate renovascular 
compromise 
-renovascular 
autoregulation is lost 
before changes in BP 
occur 
-although clinically BP is 
used as indicator for renal 
perfusion, results here 
show that BP does not 
accurately reflect RBF 
-renovascular 
autoregulation is similar 
to cerebrovascular 
autoregulation 
-kidney is more 
dependent on CO whereas 
brain is perfusion-
dependent 
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-shock state results from 
this study may be 
different than shock from 
vasoplegia and other 
causes 
Ono et al. 
(2013) 
 
Prospective 
observational 
study 
-cerebral autoregulation during CPB 
monitored by generating a cerebral 
oximetry index  
-lower limit of cerebral autoregulation 
determined for 348 patients 
-AKI developed within 7 days in 121 
patients 
-average MAP during 
CPB did not differ 
-patients who developed 
AKI had higher MAP at 
the limit of autoregulation 
and duration and degree 
to which MAP was below 
the autoregulation 
threshold (mmHg x 
min/hr of CPB) 
-MAPs below the lower 
limit of autoregulation 
were associated with 
development of AKI 
Westphal et al. 
(2012) 
 
Guidelines 
constructed by 
experts after 
extensive 
literature review 
-MAP > 65 mmHg or systolic > 90 mmHg 
-excessive use of pressors can cause 
arrhythmias, worsen hypotension 
(dobutamine), or cause intense 
vasoconstriction causing ischemia to organs 
-β agonist therapy may be helpful in low 
CO states causing hypoperfusion 
-vasopressin care be used as a pressor and 
DI treatment; may help stabilize BP and 
wean off catecholamine infusions 
-drug choice should be 
based on physiological 
principles because there 
are no randomized studies 
for best choice of pressor 
-no consensus regarding 
maximum catecholamine 
use 
Bijker et al. 
(2007) 
  
Observational, 
retrospective 
cohort study of 
non-cardiac 
surgery patients 
in the 
Netherlands 
-incidence of intraoperative hypotension 
according to different threshold values was 
calculated, and the effect of a defined 
minimal duration of a hypotensive episode 
was studied 
-no widely accepted 
definition exists of 
intraoperative 
hypotension, therefore 
there is generalizability of 
studies associating poor 
outcomes with 
intraoperative 
hypotension 
*Abbreviations in table defined: CO (cardiac output), DI (diabetes insipidus), AKI (acute kidney injury), CPB 
(cardiopulmonary bypass), ABP (arterial blood pressure), RBF (renal blood flow), CBF (cerebral blood flow), SVR 
(systemic vascular resistance), PVR (pulmonary vascular resistance), PAWP (pulmonary artery wedge pressure), 
CVP (central venous pressure), HD (hemodynamic), HDI (hemodynamic instability), HR (heart rate), CI (cardiac 
index), IVF (intravenous fluid), BD (brain death), PAC (pulmonary artery catheter), MAP (mean arterial pressure), 
kg (kilogram), BP (blood pressure), AS (autonomic storm), SNS (sympathetic nervous system), PNS (peripheral 
nervous system), ANS (autonomic nervous system), CV (cardiovascular), TEE (transesophageal echocardiogram),  
HTN (hypertension), HRT (hormone replacement therapy), EF (ejection fraction), bpm (beats per minute), BUN 
(blood urea nitrogen), mcg (micrograms), min (minute), SBP (systolic blood pressure), UO (urine output), PaO2 
(partial pressure of oxygen in arterial blood), Hgb (hemoglobin), HES ( hydroxyethyl starch), FiO2 (fraction of 
inspired oxygen) 
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Figure 1. Frequencies displayed of the mean MAP for each case. 
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Figure 2. Frequencies displayed of the mean end-tidal concentration of volatile anesthetic gas for 
cases in which volatile anesthetic gas was used. 
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Appendix A 
2010 American Academy of Neurology Guidelines for Diagnosis of Brain Death 
Checklist for determination of brain death 
 
Prerequisites (all must be checked) 
▫ Coma, irreversible and cause known 
▫ Neuroimaging explains coma 
▫ CNS depressant drug effect absent (if indicated toxicology screen; if barbiturates given, serum 
level  10 g/mL) 
▫ No evidence of residual paralytics (electrical stimulation if paralytics used). 
▫ Absence of severe acid-base, electrolyte, endocrine abnormality 
▫ Normothermia or mild hypothermia (core temperature 36°C) 
▫ Systolic blood pressure 100 mmHg 
▫ No spontaneous respirations 
 
Examination (all must be checked) 
▫ Pupils nonreactive to bright light 
▫ Corneal reflex absent 
▫ Oculocephalic reflex absent (tested only if C-spine integrity ensured) 
▫ Oculovestibular reflex absent 
▫ No facial movement to noxious stimuli at supraorbital nerve, temporomandibular joint 
▫ Gag reflex absent 
▫ Cough reflex absent to tracheal suctioning 
▫ Absence of motor response to noxious stimuli in all 4 limbs (spinally mediated reflexes are 
permissible) 
 
Apnea testing (all must be checked) 
▫ Patient is hemodynamically stable 
▫ Ventilator adjusted to provide normocarbia (PaCo2 34 – 45 mmHg) 
▫ Patient preoxygenated with 100% FiO2 for 10 minutes to PaO2 200 mmHg 
▫ Patient well-oxygenated with a PEEP of 5 cm of water 
▫ Provide oxygen via a suction catheter to the level of the carina at 6 L/min or attach T-piece 
with CPAP at 10 cm H2O 
▫ Disconnect ventilator 
▫ Spontaneous respirations absent 
▫ Arterial blood gas drawn at 8 –10 minutes, patient reconnected to ventilator 
▫ PCO2 60 mmHg, or 20 mmHg rise from normal baseline value 
OR: 
▫ Apnea test aborted 
 
Ancillary testing (only 1 needs to be performed; to be ordered only if clinical examination cannot 
be fully performed due to patient factors, or if apnea testing inconclusive or aborted) 
▫ Cerebral angiogram 
▫ HMPAO SPECT 
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▫ EEG 
▫ TCD 
 
Time of death (DD/MM/YY) _______________________ 
Name of physician and signature ____________________ 
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Appendix B 
Neuman’s Systems Model 
 
Neuman’s System Model copyright 1970 by Dr. Betty Neuman. Reproduced with permission.  
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Environments 
Interacting 
Variables 
Individual 
Stressors 
Appendix C 
Neuman’s System Model Applied to Brain Dead Donor 
 
 
 
 
 
 
 
 
 
  
 
Patient 
OR Physiologic Stressors: 
-incision 
-surgical manipulation 
-sternotomy 
Cause of ↑ ICP ↑ ICP Brain death Autonomic storm 
Internal cause (i.e. stroke) External cause (i.e. 
head trauma) 
Blood pressure 
variation 
